Stylianos Ravanidis

611 total citations
17 papers, 436 citations indexed

About

Stylianos Ravanidis is a scholar working on Genetics, Immunology and Cancer Research. According to data from OpenAlex, Stylianos Ravanidis has authored 17 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Stylianos Ravanidis's work include MicroRNA in disease regulation (5 papers), Mesenchymal stem cell research (4 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Stylianos Ravanidis is often cited by papers focused on MicroRNA in disease regulation (5 papers), Mesenchymal stem cell research (4 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Stylianos Ravanidis collaborates with scholars based in Greece, Belgium and United States. Stylianos Ravanidis's co-authors include Epaminondas Doxakis, Jeroen F. J. Bogie, Leonidas Stefanis, Niels Hellings, Anastasia Bougea, Nikolaos Papagiannakis, Piet Stinissen, Wilfried Gyselaers, Marjan Vanheusden and Matina Maniati and has published in prestigious journals such as International Journal of Molecular Sciences, Cerebral Cortex and Movement Disorders.

In The Last Decade

Stylianos Ravanidis

15 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stylianos Ravanidis Greece 11 239 155 126 69 62 17 436
Lite Ge China 13 263 1.1× 163 1.1× 133 1.1× 72 1.0× 62 1.0× 30 517
Antje Arnold United States 14 251 1.1× 108 0.7× 66 0.5× 76 1.1× 44 0.7× 24 482
Boguslawa Sadowski Germany 8 253 1.1× 106 0.7× 75 0.6× 40 0.6× 89 1.4× 8 648
Jessica Schira‐Heinen Germany 13 301 1.3× 167 1.1× 129 1.0× 83 1.2× 106 1.7× 24 605
Ali Jalali United States 12 302 1.3× 102 0.7× 117 0.9× 37 0.5× 50 0.8× 40 602
Yaobing Yao China 13 457 1.9× 157 1.0× 218 1.7× 84 1.2× 55 0.9× 28 751
Xavier Gaeta United States 7 393 1.6× 187 1.2× 113 0.9× 85 1.2× 64 1.0× 9 646
Miriam Gubernator United Kingdom 4 260 1.1× 119 0.8× 109 0.9× 38 0.6× 107 1.7× 5 416
Katsuyuki Oki Japan 6 429 1.8× 160 1.0× 254 2.0× 47 0.7× 36 0.6× 9 561
Julia Pöschl Germany 10 263 1.1× 143 0.9× 55 0.4× 68 1.0× 45 0.7× 11 499

Countries citing papers authored by Stylianos Ravanidis

Since Specialization
Citations

This map shows the geographic impact of Stylianos Ravanidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stylianos Ravanidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stylianos Ravanidis more than expected).

Fields of papers citing papers by Stylianos Ravanidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stylianos Ravanidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stylianos Ravanidis. The network helps show where Stylianos Ravanidis may publish in the future.

Co-authorship network of co-authors of Stylianos Ravanidis

This figure shows the co-authorship network connecting the top 25 collaborators of Stylianos Ravanidis. A scholar is included among the top collaborators of Stylianos Ravanidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stylianos Ravanidis. Stylianos Ravanidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ravanidis, Stylianos, et al.. (2025). A Scoping Review of POLG-Related Cerebellar Ataxia: Insights and Clinical Perspectives. Tremor and Other Hyperkinetic Movements. 15. 55–55.
2.
Lazaridou, Elizabeth, et al.. (2025). Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics. Archives of Dermatological Research. 317(1). 310–310.
3.
Lazaridou, Elizabeth, et al.. (2024). Drug survival of biologics in patients with psoriasis: real-world evidence for Greece during the period 2016–2020. Clinical and Experimental Dermatology. 49(12). 1573–1581. 1 indexed citations
4.
Ravanidis, Stylianos, Anastasia Bougea, Nikolaos Papagiannakis, et al.. (2021). Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease. Movement Disorders. 36(5). 1170–1179. 46 indexed citations
5.
Ravanidis, Stylianos, Franziska Grundler, Françoise Wilhelmi de Toledo, et al.. (2021). Fasting-mediated metabolic and toxicity reprogramming impacts circulating microRNA levels in humans. Food and Chemical Toxicology. 152. 112187–112187. 12 indexed citations
6.
Ravanidis, Stylianos, Anastasia Bougea, Nikolaos Papagiannakis, et al.. (2020). Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients. Annals of Clinical and Translational Neurology. 7(9). 1594–1607. 42 indexed citations
7.
Ravanidis, Stylianos & Epaminondas Doxakis. (2020). RNA-Binding Proteins Implicated in Mitochondrial Damage and Mitophagy. Frontiers in Cell and Developmental Biology. 8. 372–372. 21 indexed citations
8.
Ravanidis, Stylianos, Anastasia Bougea, Nikolaos Papagiannakis, et al.. (2019). Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease. Movement Disorders. 35(3). 457–467. 44 indexed citations
9.
Ravanidis, Stylianos, et al.. (2018). Unraveling the Pathways to Neuronal Homeostasis and Disease: Mechanistic Insights into the Role of RNA-Binding Proteins and Associated Factors. International Journal of Molecular Sciences. 19(8). 2280–2280. 44 indexed citations
10.
Bogie, Jeroen F. J., Stylianos Ravanidis, Pascal Gervois, et al.. (2017). Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells. Stem Cells and Development. 27(2). 65–84. 83 indexed citations
11.
Ravanidis, Stylianos, Jeroen F. J. Bogie, Robert Deans, et al.. (2017). Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells. Stem Cells International. 2017. 1–16. 4 indexed citations
12.
Morelli, Giovanni, Ariel Ávila, Stylianos Ravanidis, et al.. (2016). Cerebral Cortical Circuitry Formation Requires Functional Glycine Receptors. Cerebral Cortex. 27(3). bhw025–bhw025. 33 indexed citations
13.
Lagoudaki, Roza, Olga Touloumi, Evangelia Kesidou, et al.. (2015). Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells. Neuroscience Letters. 611. 33–39. 3 indexed citations
14.
Ravanidis, Stylianos, Jeroen F. J. Bogie, Robert W. Mays, et al.. (2015). Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells. Stem Cell Research & Therapy. 6(1). 176–176. 12 indexed citations
15.
Ravanidis, Stylianos, Roza Lagoudaki, Olga Touloumi, et al.. (2015). Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System. Stem Cells Translational Medicine. 4(12). 1450–1462. 11 indexed citations
16.
Ravanidis, Stylianos, et al.. (2015). Neuroprotective and anti-inflammatory mechanisms are activated early in Optic Neuritis. Acta Neurologica Scandinavica. 131(5). 305–312. 7 indexed citations
17.
Vanheusden, Marjan, Jeroen F. J. Bogie, Stylianos Ravanidis, et al.. (2015). Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis. Cell Transplantation. 24(10). 2077–2098. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026